Категории

IAS 2017 Rapporteur and Closing Session

Опубликовано: 17 Июль 2026
на канале: IAS Conference on HIV Science
870
7

WEPL02: Rapporteur and Closing Session. Anton Pozniak. Presented at the 9th IAS Conference on HIV Science (IAS 2017). www.ias2017.org

play_arrow
4
0

ZirCreepsAlot Plays: Ys: The Ark of Napishtim {Part 21}

ZirCreepsAlot Plays: Ys: The Ark of Napishtim {Part 21}
play_arrow
624
22

Did You Know? Filipino & English Are the Philippines' Official Languages!

Did You Know? Filipino & English Are the Philippines' Official Languages!

play_arrow
86
11

WARFACE | ОПЕРАЦИЯ BLACKWOOD | ВСЁ ПО МАКСИМУМУ

WARFACE | ОПЕРАЦИЯ BLACKWOOD | ВСЁ ПО МАКСИМУМУ
play_arrow
55
1

TRAFFIC SHARK INCOME🔔ATTENTION DON'T LEAVE🔔 THIS PAGE WITHOUT🤗YOUR BONUSES!!!

TRAFFIC SHARK INCOME🔔ATTENTION DON'T LEAVE🔔 THIS PAGE WITHOUT🤗YOUR BONUSES!!!
play_arrow
953
36

Rico Davis - Disco Lover (Official Video)

Rico Davis - Disco Lover (Official Video)
play_arrow
224
20

tr Command Tutorial amidst India's World Cup 🏆 Setback 😒

tr Command Tutorial amidst India's World Cup 🏆 Setback 😒

play_arrow
28
2

Other Animatronics Explained

Other Animatronics Explained
play_arrow
12
1

June 27, 2023

June 27, 2023
Похожие видео
play_arrow
The Mexico City story: Proud hosts of the 10th IAS Conference on HIV Science (IAS 2019)

The Mexico City story: Proud hosts of the 10th IAS Conference on HIV Science (IAS 2019)
play_arrow
On-demand Oral TDF/FTC for PrEP: Is It an Option?

On-demand Oral TDF/FTC for PrEP: Is It an Option?
play_arrow
Challenges and Opportunities in HIV Science

Challenges and Opportunities in HIV Science
play_arrow
Welcome to Paris - IAS 2017

Welcome to Paris - IAS 2017
play_arrow
TUAB0102 - Switching from a tenofovir disoproxil fumarate (TDF)-based regimen to a tenofovir ...

TUAB0102 - Switching from a tenofovir disoproxil fumarate (TDF)-based regimen to a tenofovir ...
play_arrow
TUAB0101 - Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg ...

TUAB0101 - Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg ...
play_arrow
Primary HIV Infection and Early Treatment

Primary HIV Infection and Early Treatment
play_arrow
Broadly Neutralizing Antibodies against HIV

Broadly Neutralizing Antibodies against HIV
play_arrow
Antiretroviral Therapy - ART: Season One

Antiretroviral Therapy - ART: Season One
play_arrow
Plenary Session

Plenary Session
play_arrow
IAS 2017 Rapporteur and Closing Session

IAS 2017 Rapporteur and Closing Session
play_arrow
Antiretroviral Therapy - ART: Season Two

Antiretroviral Therapy - ART: Season Two